START FREE TRIAL
Home Healthcare Waters Corporation

Waters Corporation

$19.00

SKU: WAT Category:

Description

Waters’ $1.77 Billion Revenue Quarter: Can 21% EPS Growth Continue?

 

Waters Corporation reported third-quarter 2026 results reflecting continued growth across its core and acquired businesses, with total revenue reaching $1.767 billion. Organic revenue increased 9% as reported and 10% in constant currency, driven primarily by the Analytical Sciences division’s 8% reported growth and 9% in constant currency. This performance was led by chemistry consumables (12% growth), instruments (10% growth), and service (8% growth), with strong contributions from pharma and non-pharma segments. The company highlighted particularly robust growth in China (+20%), India (mid-teens), and moderate increases in the U.S. and Europe. Biosciences and Advanced Diagnostics divisions showed more modest growth, at 2% as reported, influenced by regional dynamics such as a rebound in China for Biosciences after multiple quarters of decline and headwinds from diagnostic reagent sales in China’s Microbiology segment. Adjusted earnings per share grew 21% to $4.